Post-earnings recap
Reported
Wed, Apr 17, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Abbott Laboratories reported an EPS of $0.63, slightly missing expectations. The stock reacted negatively, dropping 4.58%. Investors may be concerned about the lack of revenue details and guidance, contributing to the stock's decline.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.63 | N/A | -0.02% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—